Manulife Investment Management (US) LLC Manulife Investment Management (North America) Limited 197 Clarendon Street Boston, MA 02216 December 14, 2023Fee Limitation Letter Agreement • April 25th, 2024 • John Hancock Collateral Trust
Contract Type FiledApril 25th, 2024 CompanyWith reference to each of the Subadvisory Agreements approved by the Board or entered into by and between Manulife Investment Management (US) LLC or Manulife Investment Management (North America) Limited, as applicable (the “Subadvisor”), and John Hancock Investment Management LLC (formerly John Hancock Advisers, LLC) or John Hancock Variable Trust Advisers LLC (formerly John Hancock Investment Management Services, LLC), as applicable, (the “Adviser”) on behalf of each of the trusts listed in Appendix A to this letter (each, a “Trust” and collectively, the “Trusts”), on behalf of each of their respective series listed in Appendix A (each, a “Fund” and collectively, the “Funds”), we hereby notify you as follows:
John Hancock Investment Management LLC 200 Berkeley Street Boston, MA 02116Expense Limitation Letter Agreement • April 25th, 2024 • John Hancock Collateral Trust
Contract Type FiledApril 25th, 2024 CompanyWith reference to the Advisory Agreement entered into by and between John Hancock Investment Management LLC (the “Adviser”) and John Hancock Collateral Trust (the “Trust”), on behalf of its series John Hancock Collateral Trust (the “Fund”), we hereby notify you as follows:
John Hancock Investment Management LLC, LLC John Hancock Variable Trust Advisers LLC 200 Berkeley Street Boston, MA 02216Fee Limitation Letter Agreement • April 25th, 2024 • John Hancock Collateral Trust
Contract Type FiledApril 25th, 2024 CompanyWith reference to the Advisory Agreements entered into by and between John Hancock Investment Management LLC, or John Hancock Variable Trust Advisers LLC, as applicable (the “Adviser”), and each of the trusts listed in Appendix A to this letter (each, a “Trust” and collectively, the “Trusts”), on behalf of each of their respective series listed in Appendix A (each, a “Fund” and collectively, the “Funds”), we hereby notify you as follows: